Article 1
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) No 487/2014 of 12 May 2014 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances Bacillus subtilis (Cohn 1872) Strain QST 713, identical with strain AQ 713, clodinafop, metrafenone, pirimicarb, rimsulfuron, spinosad, thiamethoxam, tolclofos-methyl and triticonazole Text with EEA relevance
Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) In the sixth column, expiration of approval, of row 123, clodinafop, the date β31 January 2017β is replaced by β30Β April 2018β; (2) In the sixth column, expiration of approval, of row 124, pirimicarb, the date β31 January 2017β is replaced by β30Β April 2018β; (3) In the sixth column, expiration of approval, of row 125, rimsulfuron, the date β31 January 2017β is replaced by β30Β April 2018β; (4) In the sixth column, expiration of approval, of row 126, tolclofos-methyl, the date β31 January 2017β is replaced by β30Β April 2018β; (5) In the sixth column, expiration of approval, of row 127, triticonazole, the date β31 January 2017β is replaced by β30Β April 2018β; (6) In the sixth column, expiration of approval, of row 137, metrafenone, the date β31 January 2017β is replaced by β30Β April 2018β; (7) In the sixth column, expiration of approval, of row 138, Bacillus subtilis (Cohn 1872) Strain QST 713, identical with strain AQ 713, the date β31 January 2017β is replaced by β30Β April 2018β; (8) In the sixth column, expiration of approval, of row 139, spinosad, the date β31 January 2017β is replaced by β30Β April 2018β; (9) In the sixth column, expiration of approval, of row 140, thiamethoxam, the date β31 January 2017β is replaced by β30Β April 2018β.
Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.